Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Widschwendter

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Journal of Medical Ethics|November 19, 2020
Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case studyIneke Bolt, Eline M Bunnik, Krista Tromp, et al.
Plos One|July 3, 2010
Development and validation of a method for profiling post-translational modification activities using protein microarraysSonia V Del Rincón, Jeff Rogers, Martin Widschwendter, et al.
Plos One|July 23, 2013
Corruption of the intra-gene DNA methylation architecture is a hallmark of cancerThomas E Bartlett, Alexey Zaikin, Sofia C Olhede, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 4, 2013
A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancerNatalie Nunes, Gareth Ambler, Wee-Liak Hoo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2020
A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention StrategiesGaby Sroczynski, Artemisa Gogollari, Felicitas Kuehne, et al.
BMJ Open|December 30, 2018
What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countriesOdette Wegwarth, Martin Widschwendter, David Cibula, et al.
Cancers|July 16, 2020
Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic ReviewGaby Sroczynski, Artemisa Gogollari, Annette Conrads-Frank, et al.
International Journal of Cancer|May 15, 2008
HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancerHeidi Fiegl, Gudrun Windbichler, Elisabeth Mueller-Holzner, et al.
Methods (San Diego, Calif.)|May 4, 2010
Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChipChristina Thirlwell, Marianne Eymard, Andrew Feber, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 3, 2021
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategiesNikolai Mühlberger, Gaby Sroczynski, Artemisa Gogollari, et al.
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Journal of Medical Ethics|November 19, 2020
Prevention in the age of personal responsibility: epigenetic risk-predictive screening for female cancers as a case studyIneke Bolt, Eline M Bunnik, Krista Tromp, et al.
Plos One|July 3, 2010
Development and validation of a method for profiling post-translational modification activities using protein microarraysSonia V Del Rincón, Jeff Rogers, Martin Widschwendter, et al.
Plos One|July 23, 2013
Corruption of the intra-gene DNA methylation architecture is a hallmark of cancerThomas E Bartlett, Alexey Zaikin, Sofia C Olhede, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 4, 2013
A prospective validation of the IOTA logistic regression models (LR1 and LR2) in comparison to subjective pattern recognition for the diagnosis of ovarian cancerNatalie Nunes, Gareth Ambler, Wee-Liak Hoo, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 20, 2020
A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention StrategiesGaby Sroczynski, Artemisa Gogollari, Felicitas Kuehne, et al.
BMJ Open|December 30, 2018
What do European women know about their female cancer risks and cancer screening? A cross-sectional online intervention survey in five European countriesOdette Wegwarth, Martin Widschwendter, David Cibula, et al.
Cancers|July 16, 2020
Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic ReviewGaby Sroczynski, Artemisa Gogollari, Annette Conrads-Frank, et al.
International Journal of Cancer|May 15, 2008
HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancerHeidi Fiegl, Gudrun Windbichler, Elisabeth Mueller-Holzner, et al.
Methods (San Diego, Calif.)|May 4, 2010
Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChipChristina Thirlwell, Marianne Eymard, Andrew Feber, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 3, 2021
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategiesNikolai Mühlberger, Gaby Sroczynski, Artemisa Gogollari, et al.
Pageof 18